Related references
Note: Only part of the references are listed.Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia
Yurdanur G. Acilmis et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia
Dongwei Mao et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia
Valeria C. Sandrim et al.
CLINICA CHIMICA ACTA (2010)
First-trimester maternal serum PP13 in the risk assessment for preeclampsia
Roberto Romero et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Extracellular control of TGFβ signalling in vascular development and disease
Peter ten Dijke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
Saira Salahuddin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction
Ilana Chafetz et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia
Kevin Spencer et al.
PRENATAL DIAGNOSIS (2007)
First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia
K. Spencer et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Leptin in pregnancy: facts, questions and future
J. Lepercq et al.
GYNECOLOGIE OBSTETRIQUE & FERTILITE (2007)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
SA Abdalla et al.
JOURNAL OF MEDICAL GENETICS (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound
KH Nicolaides et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2006)
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease -: Results from the AtheroGene study
R Schnabel et al.
CIRCULATION RESEARCH (2005)
Latest advances in understanding preeclampsia
CW Redman et al.
SCIENCE (2005)
Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia
SE Maynard et al.
PEDIATRIC RESEARCH (2005)
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
K Duckitt et al.
BRITISH MEDICAL JOURNAL (2005)
Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies
O Burger et al.
PLACENTA (2004)
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
F Lebrin et al.
EMBO JOURNAL (2004)
Evidence supporting a rote for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia -: Young Investigator Award
T Chaiworapongsa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia
MD Savvidou et al.
LANCET (2003)
Amniotic fluid and maternal serum leptin levels in pregnant women who subsequently develop preeclampsia
TF Chan et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2003)
Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy
LJ Salomon et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein a (PAPP-A), inhibin A, activin A, and soluble E-selectin
NA Bersinger et al.
HYPERTENSION IN PREGNANCY (2003)
Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome
Y Yaron et al.
PRENATAL DIAGNOSIS (2002)
Role of leptin in pregnancy - A review
N Sagawa et al.
PLACENTA (2002)
Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke
JH Yoo et al.
ATHEROSCLEROSIS (2001)
Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques
BA Conley et al.
ATHEROSCLEROSIS (2000)
First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
CYT Ong et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia
N Anim-Nyame et al.
HUMAN REPRODUCTION (2000)
Free leptin is increased in normal pregnancy and further increased in preeclampsia
RJ Teppa et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Serum leptin levels and the severity of preeclampsia
E Martinez-Abundis et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2000)
Share Paper
